Basic Information
| LncRNA/CircRNA Name | LINC02499 |
| Synonyms | NA |
| Region | GRCh38_4:73508803-73534128 |
| Ensemble | ENSG00000250436 |
| Refseq | NR_046377 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qRT-PCR |
| Sample | HCC tissues,cell lines |
| Expression Pattern | down-regulated |
| Function Description | up- and down-regulated LINC02499 significantly impacted proliferation, migration, and invasion abilities of HCC cells in vitro. |
| Pubmed ID | 32039538 |
| Year | 2019 |
| Title | LINC02499, a novel liver-specific lncRNA, with potential diagnostic and prognostic value, inhibits hepatocellular carcinoma cells proliferation,migration, and invasion |
External Links
| Links for LINC02499 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |